{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:40:03Z","timestamp":1778661603858,"version":"3.51.4"},"reference-count":30,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/mmr.2016.4754","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T13:04:17Z","timestamp":1452517457000},"page":"2124-2134","source":"Crossref","is-referenced-by-count":4,"title":["Antitumor effect of dendritic cells transfected with prostate-specific membrane antigen recombinant adenovirus on prostate cancer: An in vitro study"],"prefix":"10.3892","volume":"13","author":[{"given":"FAN-DONG","family":"MENG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUAI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOU-HONG","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENG-GUANG","family":"SUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"key20180108023430_b1-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11888-015-0269-2","article-title":"Immunotherapy of metastatic colorectal cancer: prevailing Challenges and new perspectives","volume":"11","author":"Zumwalt","year":"2015","journal-title":"Curr Colorectal Cancer Rep"},{"key":"key20180108023430_b2-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"e1017704","DOI":"10.1080\/2162402X.2015.1017704","article-title":"Tumor cell-derived microparticles: a new form of cancer vaccine","volume":"4","author":"Zhang","year":"2015","journal-title":"Oncoimmunology"},{"key":"key20180108023430_b3-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1631\/jzus.2005.B0001","article-title":"On dendritic cell based therapy for cancers","volume":"6","author":"Onji","year":"2005","journal-title":"Zhejiang Univ Sci B"},{"key":"key20180108023430_b4-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"key20180108023430_b5-mmr-13-03-2124","first-page":"299","article-title":"Epidemiological survey of benign prostatic hyperplasia and prostate cancer in China","volume":"113","author":"Gu","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"key20180108023430_b6-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002512-200724030-00003","article-title":"Advances in prostate cancer immunotherapies","volume":"24","author":"Basler","year":"2007","journal-title":"Drugs & Aging"},{"key":"key20180108023430_b7-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<73::AID-PROS9>3.0.CO;2-V","article-title":"Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease","volume":"38","author":"Murphy","year":"1999","journal-title":"Prostate"},{"key":"key20180108023430_b8-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<59::AID-PROS8>3.0.CO;2-D","article-title":"Higher-dose and less frequent dendritic cellinfusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients","volume":"43","author":"Murphy","year":"2000","journal-title":"Prostate"},{"key":"key20180108023430_b9-mmr-13-03-2124","first-page":"1205","article-title":"Advances in design strategy of dendritic cell vaccine","volume":"31","author":"Zhou","year":"2006","journal-title":"Medical Journal of Chinese People's Liberation Army"},{"key":"key20180108023430_b10-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1566523023348129","article-title":"Cancer immunotherapy using gene-modified dendritic cells","volume":"2","author":"Ribas","year":"2002","journal-title":"Curr Gene Ther"},{"key":"key20180108023430_b11-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1566523053544272","article-title":"Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer","volume":"5","author":"Wu","year":"2005","journal-title":"Curr Gene Ther"},{"key":"key20180108023430_b12-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.humpath.2006.11.012","article-title":"Prostate specific membrane antigen expression as a predictor of prostate cancer progression","volume":"38","author":"Perner","year":"2007","journal-title":"Hum Pathol"},{"key":"key20180108023430_b13-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/acsnano.5b02153","article-title":"Polyelectrolyte multilayers assembled entirely from immune signals on gold nanoparticle templates promote antigen-specific T cell response","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"key20180108023430_b14-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1039\/C5DT00117J","article-title":"Tetranuclear ruthenium(II) complexes with oligo-oxyethylene linkers as one-and two-photon luminescent tracking non-viral gene vectors","volume":"44","author":"Qiu","year":"2015","journal-title":"Dalton Trans"},{"key":"key20180108023430_b15-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.cr.7310032","article-title":"Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors","volume":"16","author":"Xia","year":"2006","journal-title":"Cell Res"},{"key":"key20180108023430_b16-mmr-13-03-2124","first-page":"188","article-title":"The impact of transfection with common viral vector on dendritic cells","volume":"25","author":"Zhang","year":"2003","journal-title":"Foreign Medical Science (Molecular Biology Section)"},{"key":"key20180108023430_b17-mmr-13-03-2124","first-page":"62","article-title":"Viral vector-mediated gene therapy for prostate cancer","volume":"20","author":"Liu","year":"2000","journal-title":"International Journal of Urology and Nephrology"},{"key":"key20180108023430_b18-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.vaccine.2012.11.096","article-title":"A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer","volume":"31","author":"Slovin","year":"2013","journal-title":"Vaccine"},{"key":"key20180108023430_b19-mmr-13-03-2124","first-page":"547","article-title":"Advances in prostate-specific membrane antigen targeted therapies for prostate cancer","volume":"16","author":"Wang","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"key20180108023430_b20-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.cgt.7700810","article-title":"Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo","volume":"12","author":"Medin","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"key20180108023430_b21-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/j.1939-4640.2005.tb01088.x","article-title":"Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter\/enhancer","volume":"26","author":"Zeng","year":"2005","journal-title":"J Androl"},{"key":"key20180108023430_b22-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/104303403321618146","article-title":"The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors","volume":"14","author":"Liu","year":"2003","journal-title":"Hum Gene Ther"},{"key":"key20180108023430_b23-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0308368101","article-title":"Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway","volume":"101","author":"Philpott","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"key":"key20180108023430_b24-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/86297","article-title":"A fresh look at tumor immunosurveillance and immunotherapy","volume":"2","author":"Smyth","year":"2001","journal-title":"Nat Immunol"},{"key":"key20180108023430_b25-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/vaccines3030662","article-title":"Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy","volume":"3","author":"Fan","year":"2015","journal-title":"Vaccines"},{"key":"key20180108023430_b26-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-1759(01)00545-2","article-title":"Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment","volume":"261","author":"Liu","year":"2002","journal-title":"J Immunol Methods"},{"key":"key20180108023430_b27-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4049\/jimmunol.171.2.691","article-title":"Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"key20180108023430_b28-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.exphem.2006.05.011","article-title":"Dendritic cells Pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses","volume":"34","author":"Weigel","year":"2006","journal-title":"Exp Hematol"},{"key":"key20180108023430_b29-mmr-13-03-2124","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.4049\/jimmunol.171.7.3467","article-title":"Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells","volume":"171","author":"Rivoltini","year":"2003","journal-title":"J Immunol"},{"key":"key20180108023430_b30-mmr-13-03-2124","first-page":"3235","article-title":"Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer","volume":"9","author":"Mazzaferro","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.4754\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T12:41:02Z","timestamp":1692189662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.4754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,11]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/mmr.2016.4754"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.4754","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}